Sequella

Developer of antibiotics against drug-resistant infections

placeUnited States calendar_todayFounded 1997 groups4 employees language sequella.com

Registered entities

Innovation

13 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace dormant. Cited 1,260 times.

YearFilings
20125
20135
20143
20161

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Accelerator & incubator133%
Other / undisclosed133%
Coming soon